NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Multus Biotechnology

Multus Biotechnology

Private
LondonHealthcare & Life Scienceshttps://www.multus.bio/

Last Round

Series A

Jan 16, 2023

Total Funding Raised

$9.45M

Company Overview

Multus Biotechnology is a biotechnology company that develops and supplies animal-free cell culture media for the cultivated meat and cell therapy industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Application

Keywords

cultivated meatcell culture medialab-grown meatgrowth factorscellular agriculturerecombinant proteinsfood technologybiotech ingredientsmedia formulationalt-proteincontract researchlab automationmachine learningbioprocessingprecision fermentation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Multus Biotechnology Comparables

Compare Multus Biotechnology with similar companies based on industry and business-model similarity.

Multus Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MarraBio
87%
Sticta Biologicals
84%
Deco Labs
84%

Multus Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 16, 2023
SeedJul 27, 2021
AcceleratorJun 11, 2020

Key People

Founding team and executive leadership

Kevin Pan

Co-founder CTO

Founding Team

Reka Tron

Co-founder And Fractional CFO

Founding Team

Cai Linton

Co-Founder CEO

Founding Team

Jonathan Lydiard-Wilson

Strategic Advisor To CEO

Executive Team

Multus Biotechnology Investors

Notable investors and investment history

Multus Biotechnology investors
InvestorRounds
Marinya CapitalSeed
SynBioVenSeries A
Innovate UKSeries A
IndieBioAccelerator
Mandi VenturesSeries A
Big Idea VenturesSeries A
SOSVSeed, Series A, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Added Imperial Enterprise, a biotechnology company, as a customer.

  • Oct 2, 2025

    Added FSSC as a customer

Multus Biotechnology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Multus Biotechnology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Multus Biotechnology's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range27
Year Founded2020
Last FundingJan 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.